推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

2023年12月最新中科院分区表数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎点击此处反馈给我们。

按期刊名首写字母查看 J CLIN PHARM TH最新评论：后来咋样了？ (2024-03-13)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看：


JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS期刊基本信息Hello，您是该期刊的第28549位访客

基本信息 登录收藏
期刊名字JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICSJOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

J CLIN PHARM THER
（此期刊被最新的JCR期刊SCIE收录）

LetPub评分
5.5
51人评分
我要评分

声誉
6.4

影响力
3.9

速度
9.5

期刊ISSN0269-4727
微信扫码收藏此期刊
E-ISSN1365-2710
2022-2023最新影响因子
（数据来源于搜索引擎）		2 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日：1.847
2022-2023自引率5.00%点击查看自引率趋势图
五年影响因子2.1
h-index 65
CiteScore
CiteScoreSJRSNIPCiteScore排名
3.200.5200.753
学科分区排名百分位
大类：Medicine
小类：Pharmacology (medical)		Q3145 / 260
大类：Medicine
小类：Pharmacology		Q3191 / 301

期刊简介
The Journal of Clinical Pharmacy and Therapeutics provides a forum for clinicians, pharmacists and pharmacologists to explore and report on issues of common interest. Reports and commentaries on current issues in medical and pharmaceutical practice are encouraged. Papers on evidence-based clinical practice and multidisciplinary collaborative work are particularly welcome. Regular sections in the journal include: editorials, commentaries, reviews (including systematic overviews and meta-analyses), original research and reports, and book reviews. Its scope embraces all aspects of clinical drug development and therapeutics, including:

Rational therapeutics
Evidence-based practice
Safety, cost-effectiveness and clinical efficacy of drugs
Drug interactions
Clinical impact of drug formulations
Pharmacogenetics
Personalised, stratified and translational medicine
Clinical pharmacokinetics.
期刊官方网站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2710
期刊投稿网址https://mc.manuscriptcentral.com/jcpt
期刊语言要求Language
Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS的语言要求，还能让JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS编辑和审稿人得到更好的审稿体验，让稿件最大限度地被JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿
是否OA开放访问No
通讯方式WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148
出版商Wiley-Blackwell Publishing Ltd
涉及的研究方向医学-药学
出版国家或地区ENGLAND
出版语言English
出版周期Bimonthly
出版年份1987
年文章数 202点击查看年文章数趋势图
Gold OA文章占比82.23%
研究类文章占比：
文章 ÷（文章 + 综述）		78.22%
WOS期刊SCI分区
（ 2022-2023年最新版）		WOS分区等级：4区

按学科分区JIF分区JIF排名JIF百分位
学科：PHARMACOLOGY & PHARMACY
类别：SCIE		Q4218/277
中科院《国际期刊预警
名单（试行）》名单 		2024年02月发布的2024版：不在预警名单中

2023年01月发布的2023版：不在预警名单中

2021年12月发布的2021版：不在预警名单中

2020年12月发布的2020版：不在预警名单中
中科院SCI期刊分区
（ 2023年12月最新升级版） 		点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区4区3区
PHARMACOLOGY & PHARMACY
药学		4区2区4区
否否
中科院SCI期刊分区
（ 2022年12月升级版）
大类学科小类学科Top期刊综述期刊
医学 2区4区2区
PHARMACOLOGY & PHARMACY
药学		4区1区4区
否否
中科院SCI期刊分区
（ 2021年12月旧的升级版）
大类学科小类学科Top期刊综述期刊
医学 2区4区4区
PHARMACOLOGY & PHARMACY
药学		2区3区4区
否否
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0269-4727%5BISSN%5D
平均审稿速度网友分享经验：
偏慢,4-8周
平均录用比例网友分享经验：
容易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS顺利发表。
快看看作者怎么说吧：服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    DRUG RESISTANCE UPDATES10034.80
    PHARMACOLOGICAL REVIEWS21030.70
    ADVANCED DRUG DELIVERY REVIEWS27823.30
    TRENDS IN PHARMACOLOGICAL SCIENCES20123.30
    PHARMACOLOGY & THERAPEUTICS18021.10
    MEDICINAL RESEARCH REVIEWS11926.60
    PHARMACOLOGICAL RESEARCH11815.80
    PHYTOMEDICINE10510.40
    BIOMEDICINE & PHARMACOTHERAPY7812.60
    DRUG DISCOVERY TODAY15714.70
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE608762
    BIOMATERIALS518985
    BIOMEDICINE & PHARMACOTHERAPY472111
    Journal of Materials Chemistry B464037
    Frontiers in Pharmacology456455
    Frontiers in Immunology428349
    JOURNAL OF ETHNOPHARMACOLOGY411189
    COLLOIDS AND SURFACES B-BIOINTERFACES407468
    Frontiers in Oncology389045
    Acta Biomaterialia380358
  •  

    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    我来预测明年：
    稳步上升 表现平稳 逐渐下降　 刷新
  •  

    		  
  •  

    		  
  •  

    		  
  • 中国学者近期发表的论文
    1.Comparation of vancomycin penetration into cerebrospinal fluid in postoperative intracranial infection and community-acquired meningitis patients.

    Author: Cai Y1, Zhou L2, Wang H3, Zhang L1, Wang J1, Zhang K1.
    Journal: J Clin Pharm Ther. 2019 Apr;44(2):216-219. doi: 10.1111/jcpt.12770. Epub 2018 Oct 27.        PubMed      DOI
    2.Recognition of the toxicity of aristolochic acid.

    Author: Zhang HM1, Zhao XH2, Sun ZH1, Li GC3, Liu GC4, Sun LR1, Hou JQ5, Zhou W1.
    Journal: J Clin Pharm Ther. 2019 Apr;44(2):157-162. doi: 10.1111/jcpt.12789. Epub 2018 Dec 11.        PubMed      DOI
    3.Association between aripiprazole pharmacokinetics and CYP2D6 phenotypes: A systematic review and meta-analysis.

    Author: Zhang X1, Xiang Q1, Zhao X1, Ma L1, Cui Y1.
    Journal: J Clin Pharm Ther. 2019 Apr;44(2):163-173. doi: 10.1111/jcpt.12780. Epub 2018 Dec 18.        PubMed      DOI
    4.Similarity-based machine learning support vector machine predictor of drug-drug interactions with improved accuracies.

    Author: Song D1,2, Chen Y3, Min Q3, Sun Q3, Ye K4, Zhou C3, Yuan S3, Sun Z2, Liao J3,5.
    Journal: J Clin Pharm Ther. 2019 Apr;44(2):268-275. doi: 10.1111/jcpt.12786. Epub 2018 Dec 18.        PubMed      DOI
    5.Tumour necrosis factor-α gene -308 G > A and -238 G > A polymorphisms are associated with susceptibility to irritable bowel syndrome and drug efficacy in children.

    Author: Sun MH1, Sun LQ1, Guo GL2, Zhang S1.
    Journal: J Clin Pharm Ther. 2019 Apr;44(2):180-187. doi: 10.1111/jcpt.12775. Epub 2018 Dec 21.        PubMed      DOI
    6.Comparison of efficacy and safety between febuxostat and allopurinol in early post-renal transplant recipients with new onset of hyperuricemia.

    Author: Shen X1,2, Li J3, Fu Q4, Liu L4, Gao X1, Chen X1, Chen P1, Wang C4.
    Journal: J Clin Pharm Ther. 2019 Apr;44(2):318-326. doi: 10.1111/jcpt.12794. Epub 2018 Dec 23.        PubMed      DOI
    7.Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials.

    Author: Yang T1, Zhou Y1, Chen C1, Lu M1, Ma L1, Cui Y1.
    Journal: J Clin Pharm Ther. 2019 Apr;44(2):197-208. doi: 10.1111/jcpt.12782. Epub 2018 Dec 28.        PubMed      DOI
    8.Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy.

    Author: Chen CY1, Zhou Y1,2, Cui YM1,2, Yang T1, Zhao X1,2, Wu Y3.
    Journal: J Clin Pharm Ther. 2019 Apr;44(2):300-311. doi: 10.1111/jcpt.12792. Epub 2019 Jan 12.        PubMed      DOI
    9.Efficacy and safety of ipilimumab for treating advanced melanoma: A systematic review and meta-analysis.

    Author: Li J1, Gu J1.
    Journal: J Clin Pharm Ther. 2019 Jun;44(3):420-429. doi: 10.1111/jcpt.12802. Epub 2019 Jan 28.        PubMed      DOI
    10.A case of simvastatin-induced myopathy with SLCO1B1 genetic predisposition and co-ingestion of linagliptin and Stevia rebaudiana.

    Author: Chan JCM1,2, Ng MH2, Wong RSM1,2, Tomlinson B1.
    Journal: J Clin Pharm Ther. 2019 Jun;44(3):381-383. doi: 10.1111/jcpt.12805. Epub 2019 Feb 3.        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    HARVARD BUSINESS REVIEW02.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.10
    Energy Material Advances08.50
    CLINICAL AND EXPERIMENTAL HYPERTENSION453.60
    Journal of Public Transportation07.00
    Asian Journal of Psychiatry010.90
    Chinese Journal of Population Resources and Environment02.60
    VIEW08.60
    HLA933.00
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY011.50


以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分：

    同领域作者分享投稿经验：共70条 （包含回复）

 我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

    增值电信业务经营许可证：沪B2-20211595

    礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451